CD8B and neoplasm: Approximately four weeks after cell line challenge, tumours continued to grow in the majority of mice depleted of CD8β+ T cells or TCRβ+ T cells, but not in mice depleted of CD4+ T cells (Supplementary Figure S1C), suggesting that CD8+ T cells also play a vital role in the prevention of SCC tumour progression.